Some older adults with diabetes overtreated for their disease
the ONA take:
According to a new study published in JAMA Internal Medicine, many older adults with diabetes are being overtreated for their disease.
For the study, researchers from Yale University School of Medicine in New Haven, Connecticut, identified nearly 1,300 adults aged 65 years and older with diabetes from the National Health and Nutrition Examination Survey (NHANES) and separated them into three cohorts depending on their state of health: relatively healthy, complex/intermediate health, and very complex/poor health.
Results showed that among all participants, 61.5% had tight glycemic control, which was defined as an A1C less than 7%. In the relatively healthy group, 62.8% had tight glycemic control compared with 63% of those in the complex/intermediate health group and 56.4% of those in the very complex/poor health group.
In addition, about 55% of patients were treated with either sulfonylureas or insulin. Although the American Diabetes Association recommends an A1C level less than 7% among patients with diabetes, older patients are more susceptible to hypoglycemia and may benefit less from such tight glycemic control.
Those with diabetes in complex/intermediate or very complex/poor health are at a higher risk of treatment-related harms and less likely to derive benefit from intensive glycemic control.
Many older adults with diabetes are being overtreated for their disease.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|